This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

INCB18424 (Topical)

Incyte Corporation

Drug Names(s): INC424, ruxolitinib

Description: BioMedTracker has separate drug profiles for INCB18424. Please also see INCB18424 (Oral).

INCB18424 is a janus-associated kinase (JAK) inhibitor.


INCB18424 (Topical) News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug